These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1800929

  • 1. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH, Tabbara KF.
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [Abstract] [Full Text] [Related]

  • 2. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Nanba K, Fukushima A, Fujishima H.
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
    Akpek EK, Hasiripi H, Christen WG, Kalayci D.
    Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822
    [Abstract] [Full Text] [Related]

  • 4. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A, Gürler B.
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [Abstract] [Full Text] [Related]

  • 5. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
    Kosrirukvongs P, Luengchaichawange C.
    J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study.
    Jain AK, Sukhija J.
    Indian J Ophthalmol; 2006 Jun; 54(2):111-6. PubMed ID: 16770028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S, Nkurikiye J, Fonteyne Y, Tuft S, De Bacquer D, Gilbert C, Kestelyn P.
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A, Gupta R, Ram J, Gupta A.
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, O'Brien TP, Schein OD, Gottsch JD.
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M, Zicari AM, Celani C, Lollobrigida V, Grenga R, Duse M.
    Semin Ophthalmol; 2015 Mar; 30(5-6):340-4. PubMed ID: 24571721
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.